CD34+ dermal dendritic cells and mucin deposition in dermatomyositis

doi:10.5314/wjd.v5.i2.65

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

(346)

(448)

(0)

(7736)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Dermatology

ISSN

2218-6190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Diagnostic Advances

World J Dermatol. May 2, 2016; 5(2): 65-71
Published online May 2, 2016. doi: 10.5314/wjd.v5.i2.65

Full Size Figure Download Figure

Figure 4 Proposed pathogenic mechanism underlying dermal mucin deposition in dermatomyositis. α-SMA: α-smooth muscle actin; N: Nucleus; TSHR: Thyroid-stimulating hormone receptor; HAS: Hyaluronan synthase.

Citation: Yokoyama E, Nakamura Y, Okita T, Nagai N, Muto M. CD34+ dermal dendritic cells and mucin deposition in dermatomyositis. World J Dermatol 2016; 5(2): 65-71
URL: https://www.wjgnet.com/2218-6190/full/v5/i2/65.htm
DOI: https://dx.doi.org/10.5314/wjd.v5.i2.65

Yokoyama E, Nakamura Y, Okita T, Nagai N, Muto M. CD34+ dermal dendritic cells and mucin deposition in dermatomyositis. World J Dermatol 2016; 5(2): 65-71 [DOI: 10.5314/wjd.v5.i2.65]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.